Canada's Knight Therapeutics Inc and shareholders of Biotoscana Investments expect to conclude transfer of control of the Latin American pharmaceutical company by Nov. 29, the latter said in a securities filing on Monday.
from Reuters: Company News https://ift.tt/2qKOOOL
via IFTTT
0 comments:
Post a Comment